Oxford vaccine to cost Rs 200 per dose in India

Dhaka, Bangladesh || Wednesday, 24 April 2024 || 10 Boishakh 1431

HEADLINE:

Kazi Zarzees bin Ertaza steps to 21 today Bashundhara MD honoured with ‘TRAB Smart Performance Award’ Today 20th death anniversary of Shahidur Rahman, the bright star of Judiciary President appoints Sheikh Hasina as Prime Minister First woman barrister on Board of Directors of Gulshan Club Bangladesh Army and Canadian University of Bangladesh Sign Memorandum of Understanding DNCC, Borak Real Estate sign deal, Sheraton goes into full swing

From pandemic to Padma bridge: Will the anti-Hasina brigade ever learn?

The anti-Sheikh Hasina brigade has been paid back fair

No one remembers the bravery of Badruzzamanan in '71

Badruzzaman Badrul, the expatriate son of a brave martyr

'Minar-e Kabir', the highest Islamic Monument in Jhalokati

Minar-e Kabir is a minaret located in Sugandia village

Bashundhara Group gets ‘Best Brand’ recognition

Bashundhara Group, the country’s largest business conglomerate, has been

http://www.dailyvorerpata.com/ad/72890.jpg

Oxford vaccine to cost Rs 200 per dose in India

Published : Tuesday, 12 January, 2021 at 11:38 AM, Count : 378

Oxford vaccine to cost Rs 200 per dose in India

The Covishield vaccine manufactured by the Serum Institute of India (SII) will be priced at ? 200 a vial after a price agreement was arrived at with the government, sources have said.

The first 100 million doses will be priced ? 200, say SII sources, and the initial tranche to be supplied is expected to be 11 million doses, reports NDTV.

The drug is expected to roll out of SII's Pune facilities tonight or tomorrow morning.

"The price is fixed in writing,'' said sources in the SII adding that exports of the life-saving vaccine are expected after January 16 as well.

"A few million doses of Covishield will be supplied every week. 11 million doses may be supplied in the initial lot," they added.

The process of administering the vaccine will start on on January 16, the government said on the weekend.

The SII vaccine developed by Oxford-AstraZeneca was cleared for emergency use along with Bharat Biotech's indigenous "Covaxin" earlier this month.

« Previous

The glorious journey of Bangladesh Community in Portugal

Sayem Sobhan Anvir: Unique general business icon

“Carelessly written prescriptions by Bangladeshi doctors can cause dangerous physical damage for patients and sometimes even leads to death”

United Hospital accused of taking patient off life support after COVID-19 diagnosis

http://www.dailyvorerpata.com/ad/300x250.jpg

© Daily Peoples Time

News & Commercial Office:
93, Kazi Nazrul Islam Avenue, Kawran Bazar, Dhaka-1215
Phone: 88-02-41010087, 41010086, Fax: 88-02-41010085, Advertising: 88-02-41010084
E-mail: [email protected]

Developed & Maintenance by i2soft